|
76488
|
(S)-(+)-4-(3-Amino-pyrrolidino)-7-nitrobenzofurazan
|
≥98.0% (HPLC)
|
λex ≥490 nm; λem ≥535 nm in acetonitrile
|
|
|
|
|
70684
|
1-(2-Naphthoyl)imidazole
|
≥95.0% (N)
|
λex 234 nm; λem 274 nm in H2O λex 234 nm; λem 374 nm (after derivatization)
|
|
|
|
|
69025
|
1-Methylpyrene
|
≥97.0% (TLC)
|
λex 340 nm; λem 486 nm in chloroform λex 346 nm; λem 378 nm in DMSO
|
|
|
|
|
68617
|
10-Methyl-9-(phenoxycarbonyl)acridinium fluorosulfonate
|
≥90% (HPLC)
|
|
|
|
|
|
43775
|
2,2′-Dithiodi(1-naphthylamine)
|
≥97.0% (CHN)
|
|
|
|
|
|
64958
|
2-Methoxy-2,4-diphenyl-3(2H)-furanone
|
≥98.0% (HPLC)
|
λex 384 nm; λem 472 nm in acetonitrile (after derivatization with hexylamine)
|
|
|
|
|
57676
|
2-[4-(Iodoacetamido)phenyl]-6-methylbenzothiazole
|
≥90% (TLC)
|
λex 345 nm; λem 383 nm in methanol
|
|
|
|
|
06627
|
2-Aminoacridone
|
≥98.0% (HPLC)
|
λex 420 nm; λem 538 nm in 0.1 M Tris pH 8.0
|
|
|
|
|
30423
|
3-(Dansylamino)phenylboronic acid
|
≥98.0% (HPLC)
|
λex 337 nm; λem 490 nm (Protein adduct) λex 337 nm; λem 517 nm in methanol
|
|
|
|
|
17631
|
3-Bromomethyl-7-methoxy-1,4-benzoxazin-2-one
|
≥97.0%
|
λex 343 nm; λem 430 nm
|
|
|
|
|
93088
|
4-(2-Aminoethylamino)-7-(N,N-dimethylsulfamoyl)benzofurazan
|
≥99.0% (HPLC)
|
λex 406 nm; λem 581 nm in 0.1 M phosphate pH 7.0
|
|
|
|
|
17623
|
4-Bromomethyl-7-methoxycoumarin
|
≥97.0% (HPLC)
|
λex 312 nm; λem 395 nm in methanol
|
|
|
|
|
25455
|
4-Chloro-7-nitrobenzofurazan
|
≥97.0% (HPLC)
|
λex 336 nm in methanol λex 420 nm; λem ~540 nm in ethanol (after derivatization with glycine)
|
|
|
|
|
21965
|
5(6)-Carboxy-X-rhodamine
|
|
λex 570 nm; λem ~595 nm in 0.1 M Tris pH 8.0
|
|
|
|
|
21966
|
5(6)-Carboxy-X-rhodamine N-succinimidyl ester
|
|
λex 575 nm; λem 605 nm in 0.1 M phosphate pH 7.0
|
|
|
|
|
21878
|
5(6)-Carboxyfluorescein N-hydroxysuccinimide ester
|
≥80% (HPLC)
|
λex 492 nm; λem 517 nm in DMF
|
|
|
|
|
21953
|
5(6)-Carboxytetramethylrhodamine
|
≥85% (sum of isomers, HPCE)
|
λex 543 nm; λem 572 nm in methanol
|
|
|
|
|
21955
|
5(6)-Carboxytetramethylrhodamine N-succinimidyl ester
|
≥70% (coupling to amines)
|
λex 543 nm; λem 576 nm in methanol λex 554 nm; λem 584 nm in 0.1 M phosphate pH 8.0
|
|
|
|
|
63184
|
5-Maleimido-eosin
|
≥93% (HPLC)
|
λex 524 nm; λem 545 nm (after derivatization with 2-mercaptoethanol)
|
|
|
|
|
38737
|
6,7-Dimethoxy-4-coumarinylacetic acid
|
≥98.0% (TLC)
|
λex 342 nm; λem 418 nm in methanol
|
|
|
|
|
46940
|
6-[Fluorescein-5(6)-carboxamido]hexanoic acid N-hydroxysuccinimide ester
|
≥75% (HPLC)
|
λex 490 nm; λem 514 nm (pH 8.2) λex 491 nm; λem 515 nm in 0.1 M Tris pH 9.0
|
|
|
|
|
07985
|
6-Aminofluorescein
|
~95% (HPLC)
|
λex 490 nm; λem 520 nm in 0.1 M Tris pH 9.0
|
|
|
|
|
08445
|
7-Amino-4-methyl-3-coumarinylacetic acid
|
~90% (HPLC)
|
λex 350 nm; λem 433 nm in methanol
|
|
|
|
|
46640
|
7-Fluorobenzofurazan-4-sulfonic acid ammonium salt
|
≥98.5% (HPLC)
|
λex 385 nm; λem 524 nm in 0.1 M borate pH 9.5 (after derivatization with glutathione)
|
|
|
|
|
55634
|
7-Hydroxy-4-methyl-3-coumarinylacetic acid
|
≥98.0% (HPLC)
|
λex 360 nm; λem ~450 nm in 0.1 M Tris pH 9.0
|
|
|
|
|
55156
|
7-Hydroxycoumarin-3-carboxylic acid N-succinimidyl ester
|
≥95.0% (coupling assay to aminopropyl silica gel)
|
λex 386 nm; λem 448 nm in 0.1 M Tris pH 9.0
|
|
|
|
|
56059
|
7-Hydroxy-N-octadecylcoumarin-3-carboxamide
|
≥98.0% (TLC)
|
λex 359 nm; λem 406 nm in chloroform/DMSO (1:1)
|
|
|
|
|
09341
|
8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt
|
≥96.0% (HPCE)
|
λex 420 nm; λem 500 nm in 0.1 M Tris pH 7.4 (quenching with Vitamin B1) λex 488 nm; λem 520 nm(lit.)
|
|
|
|
|
59818
|
8-Isothiocyanatopyrene-1,3,6-trisulfonic acid trisodium salt
|
≥95.0% (HPCE)
|
λex 401 nm; λem 421 nm in 0.1 M phosphate pH 7.0
|
|
|
|
|
87207
|
8-Tetradecyloxypyrene-1,3,6-trisulfonic acid trisodium salt
|
≥95% (TLC)
|
λex 404 nm; λem 434 nm in H2O
|
|
|
|
|
88886
|
9-(Bromomethyl)acridine
|
≥97.0% (HPLC)
|
λex 335 nm; λem 447 nm in 0.1 M phosphate pH 7.0 (after derivatization with glutathione)
|
|
|
|
|
10603
|
9-Anthracenecarboxaldehyde
|
≥97.0% (HPLC)
|
|
|
|
|
|
46917
|
9-Fluorenylmethyl carbazate
|
≥99.0% (HPLC) ≥99.0%
|
λex 264 nm; λem 309 nm in methanol λex 270 nm; λem 320 nm (Saccharide adducts)
|
|
|
|
|
12715
|
Benzo[f]ninhydrin monohydrate
|
≥98.0% (HPLC)
|
|
|
|
|
|
39220
|
Dansyl chloride
|
≥99.0% (HPLC)
|
λex 337 nm; λem 492 nm in chloroform (after derivatization with hexylamine)
|
|
|
|
|
30434
|
Dansylhydrazine
|
≥90% (HPLC)
|
λex 340 nm; λem 525 nm in ethanol
|
|
|
|
|
43095
|
Diphenylmaleic anhydride
|
≥98.0% (HPLC)
|
λex 284 nm; λem 506 nm (after derivatization with hexylamine)
|
|
|
|
|
F1058
|
FSL-Fluorescein
|
|
|
|
|
|
|
F9182
|
FSL-biotin
|
|
|
|
|
|
|
46950
|
Fluorescein 5(6)-isothiocyanate
|
≥90% (HPLC)
|
λex 492 nm; λem 518 nm in 0.1 M phosphate pH 8.0
|
|
|
|
|
46939
|
Fluorescein diacetate 5-maleimide
|
|
λex 492 nm; λem 530 nm in 0.1 M phosphate pH 7.0 (after derivatization with 2-mercaptoethanol and after cleavage by esterase)
|
|
|
|
|
46985
|
Fluorescein-5-thiosemicarbazide
|
~80% (HPCE)
|
λex 492 nm; λem 516 nm in 0.1 M Tris pH 9.0
|
|
|
|
|
46930
|
Fluoresceinamine
|
≥75% (calc. on anhydrous substance, HPLC/T)
|
λex 234 nm in acetonitrile (Amine adducts) λex 381 nm; λem 470 nm (Do not confuse with fluorescamine.)
|
|
|
|
|
57672
|
N-(Iodoacetaminoethyl)-1-naphthylamine-5-sulfonic acid
|
≥95% (HPLC)
|
λex 336 nm; λem 490 nm (pH 8.0) λex 337 nm; λem 498 nm (after derivatization with 2-mercaptoethanol)
|
|
|
|
|
12266
|
N-[4-(2-Benzimidazolyl)phenyl]maleimide
|
≥98.0% (HPLC)
|
λex 315 nm; λem 365 nm (after derivatization with 2-mercaptoethanol)
|
|
|
|
|
15167
|
NIR-797 isothiocyanate
|
≥70% (coupling to amines)
|
λex 795 nm; λem 817 nm in 0.1 M phosphate pH 7.0
|
|
|
|
|
79760
|
Phthaldialdehyde
|
≥99.0% (HPLC)
|
λex 334 nm; λem 455 nm (Thiol Adduct) λex 340 nm; λem 450 nm in reaction buffer (with glycine)
|
|
|
|
|
09969
|
SQ-NHS
|
>50% (coupling to amines)
|
λex 600 nm; λem 645 nm in 0.1 M phosphate pH 7.0
|
|
|
|
|
87918
|
Tetramethylrhodamine isothiocyanate mixed isomers
|
|
λex 529 nm; λem 596 nm in DMSO
|
|
|
|